EMS Limited (EMSLIMITED)

Utilities · Other Utilities · NSE · Updated 15 July 2026

₹429.55 ↓ 30% (1Y)

🎯 Key Takeaways

EMS Limited is in a recovery and expansion phase, transitioning from temporary operational headwinds to structured growth. Management attributes recent revenue suppression to external delays in government permissions and payments, but sees a clear path to normalization and accelerated growth in FY27.
Revenue grew 5.1% QoQ to ₹245 in Q3FY25.
⚠️ Prolonged delays in government permissions and payments could continue to suppress revenue realization and margin recovery.

Market Cap

₹1,803

P/E Ratio

9.6

Div Yield

0.00%

Promoter

0.0%

✨ Ask AI About EMSLIMITED 📊 Interactive Charts

📖 The Story

EMS Limited is in a recovery and expansion phase, transitioning from temporary operational headwinds to structured growth. Management attributes recent revenue suppression to external delays in government permissions and payments, but sees a clear path to normalization and accelerated growth in FY27. The company is leveraging a strong order book and strategic partnerships to drive long-term value creation.

📰 What's Happening

In Q4 FY26, EMS Limited reported consolidated revenue of ₹732 crores with PAT margin at 15%, though standalone Q4 revenue was significantly impacted by a ₹100 crore inventory buildup due to delayed government permissions and payment issues. Management highlighted that revenue could have reached ₹250 crores in Q4 absent these delays. The order book stands at ₹1,837 crores, including ₹209 crores from UP Jal Nigam, with a target of ₹1,000 crores revenue from new work in FY27. Management projects 20-25% CAGR in long-term growth and expects PAT margin to stabilize at 15% with EBITDA at ~25% in FY27. A routine general filing was submitted on June 19, 2026, with no material updates.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Q2FY24	Q3FY24	Q4FY24	Q1FY25	Q2FY25	Q3FY25
Revenue	211	200	245	206	233	245
Operating Profit	65	53	68	53	71	74
OPM %	27.1%	23.5%	27.6%	24.4%	29.4%	29.0%
Net Profit	45	37	47	37	50	51
EPS	₹9.39	₹7.37	₹9.14	₹6.68	₹8.94	₹9.09

Revenue trends show volatility, with standalone Q4 FY26 revenue at ₹84 crores down from ₹120 crores consolidated, primarily due to inventory buildup rather than weak demand. However, quarterly performance from Q1FY25 to Q3FY25 indicates improving operational efficiency, with OPM stabilizing around 27-29% and EPS rising from ₹6.68 to ₹9.09. The sequential recovery in operating performance suggests that once inventory issues resolve, margins and revenue growth are expected to normalize. Management expects margin expansion to 15-17% post-clearance, aligning with historical profitability levels.

🔮 Management Outlook & What's Next

Management projects PAT margin of 15% and EBITDA of ~25% in FY27, underpinned by ₹1,000 crores in new revenue from the order book, including ₹209 crores from UP Jal Nigam. They anticipate 20-25% compound annual growth over the long term, driven by project execution and resolution of external delays. PAT margin is expected to normalize to 15-17% once inventory clears, reflecting confidence in operational recovery. No specific timelines were provided for inventory resolution, but the focus on project ramp-up and revenue visibility from backlog was emphasized.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Other Utilities

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
VA Tech Wabag Limited	8,637	34.4	—	—	—
ION Exchange (India) Limited	5,722	26.3	—	—	—
Enviro Infra Engineers Limited	3,393	16.3	—	—	—
EMS Limited	1,803	9.6	—	—	—
Antony Waste Handling Cell Limited	1,338	18.4	—	—	—
Denta Water and Infra Solutions Limited	702	10.7	—	—	—
Concord Enviro Systems Limited	600	11.2	—	—	—
Race Eco Chain Limited	226	37.4	—	—	—

🔗 Peer Stock Analyses

WABAG IONEXCHANG EIEL AWHCL DENTA

⚠️ Risk Factors

1. Prolonged delays in government permissions and payments could continue to suppress revenue realization and margin recovery. 2. Execution risk in new project delivery, particularly in the power sector, may impact order book conversion to revenue. 3. Margin improvement is contingent on inventory clearance and project ramp-up, making timing a critical uncertainty. 4. High reliance on a single large client (UP Jal Nigam) introduces concentration risk in new order execution.

📋 Recent Filings

🧠 Analyst's Read

EMS Limited is navigating temporary operational disruptions but maintains a credible growth narrative supported by a robust order book and long-term targets. Investors should monitor progress on resolving external delays and the pace of project execution in FY27, as these will determine whether margin and revenue recovery materializes as projected. The current valuation reflects skepticism, but execution clarity could drive re-rating.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on EMSLIMITED

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-15.

📡 Get AI alerts when EMSLIMITED files new disclosures

Track EMSLIMITED filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track EMSLIMITED — Free

Free account · 2 AI queries/day